bf/NASDAQ:ELEV_icon.jpeg

NASDAQ:ELEV

Elevation Oncology, Inc.

  • Stock

USD

Last Close

3.61

17/05 20:00

Market Cap

117.06M

Beta: -

Volume Today

173.09K

Avg: 819.79K

PE Ratio

−2.16

PFCF: −1.98

Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
15K
-
18K
20%
27K
50%
39K
44.44%
gross profit
-15K
-
-18K
20%
-27K
50%
-39K
44.44%
selling and marketing expenses
543.18K
-
-39K
-
general and administrative expenses
816
-
1.80M
220,488.24%
8.45M
369.50%
15.83M
87.34%
14.90M
5.86%
selling general and administrative expenses
544K
-
1.80M
230.88%
8.45M
369.50%
15.83M
87.34%
14.87M
6.11%
research and development expenses
5.34M
-
15.48M
189.92%
23.59M
52.46%
78.72M
233.62%
25.43M
67.69%
other expenses
11K
-
7K
36.36%
-506K
7,328.57%
5.11M
1,109.29%
cost and expenses
5.88M
-
17.28M
193.71%
32.05M
85.49%
94.55M
195.04%
40.34M
57.34%
operating expenses
5.88M
-
17.28M
193.71%
32.05M
85.49%
94.55M
195.04%
40.30M
57.38%
interest expense
479K
-
4.17M
770.15%
ebitda
-5.88M
-
-17.26M
193.45%
-32.03M
85.55%
-94.55M
195.21%
-40.30M
57.38%
operating income
-5.88M
-
-17.28M
193.71%
-32.05M
85.49%
-94.55M
195.04%
-40.34M
57.34%
depreciation and amortization
3.57K
-
15K
319.82%
18K
20%
27K
50%
39K
44.44%
total other income expenses net
-5.25K
-
11K
309.52%
7K
36.36%
-506K
7,328.57%
-5.34M
954.55%
income before tax
-5.88M
-
-17.27M
193.52%
-32.04M
85.57%
-95.06M
196.69%
-45.67M
51.95%
income tax expense
-8.82K
-
25K
-
30K
20%
net income
-5.88M
-
-17.27M
193.52%
-32.04M
85.57%
-95.08M
196.76%
-45.70M
51.93%
weighted average shs out
23.76M
-
23.76M
0%
23.21M
2.33%
23.27M
0.26%
34.08M
46.46%
weighted average shs out dil
23.76M
-
23.76M
0%
23.21M
2.33%
23.27M
0.26%
34.08M
46.46%
eps
-0.25
-
-0.73
192%
-1.38
89.04%
-4.09
196.38%
-1.34
67.24%
epsdiluted
-0.25
-
-0.73
192%
-1.38
89.04%
-4.09
196.38%
-1.34
67.24%

All numbers in USD (except ratios and percentages)